LAMP1 and neoplasm: Our results confirmed that LAMP1 and LC3-II expressions were overexpressed in SDS-203 treated tumor samples compared to vehicle control or NH4Cl only treated tumor samples. Collectively, our in vivo data demonstrated that SDS-203 was equally effective in the upregulation of lysosomes in tumor cells that resulted in the reduction of tumor burden in mice.